EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase I)Klinische Studie (Phase II)Open Access

A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence

Emily Bivens, Omar Atiq, Teresa Evans, Milan Bimali, Ginger Brown, Jasmine Crane, Nadia Darwish, Jennifer L Faulkner, Rangaswamy Govindarajan, Aaron Johnson, Alongkorn Kurilung, Oxana Lazarenko und 10 weitere

Oncotarget · 05.06.2026 · 17 (1) · 291-305

DOI: 10.18632/oncotarget.28892 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Oncotarget, erschienen am 05.06.2026. Verfasst von Emily Bivens und 21 weiteren Autor:innen. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Neoplasm Recurrence, Local, Papillomavirus Vaccines, Carcinoma, Squamous Cell. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Head and Neck NeoplasmsNeoplasm Recurrence, LocalPapillomavirus VaccinesCarcinoma, Squamous CellPapillomavirus InfectionsCancer VaccinesHumansFemaleMiddle AgedMaleDouble-Blind MethodAdultAgedSquamous Cell Carcinoma of Head and NeckTreatment Outcome

Stichwörter der Autor:innen

adjuvantclinical trialhead and neck cancerhuman papillomavirustherapeutic vaccine

Substanzen

Papillomavirus VaccinesCancer Vaccines

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Bivens, E., Atiq, O., Evans, T., Bimali, M., Brown, G., Crane, J., Darwish, N., Faulkner, J. L., Govindarajan, R., Johnson, A., Kurilung, A., Lazarenko, O., Lu, Y. W., Marsh, K., Moreno, M., Nookaew, I., Robeson, M., Sunde, J., Ussery, D., …, & Nakagawa, M. (2026). A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence. Oncotarget, 17(1), 291-305. https://doi.org/10.18632/oncotarget.28892

Vancouver

Bivens E, Atiq O, Evans T, Bimali M, Brown G, Crane J, et al. A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence. Oncotarget. 2026;17(1):291-305. doi:10.18632/oncotarget.28892

BibTeX
@article{Bivens2026,
  author = {Bivens, Emily and Atiq, Omar and Evans, Teresa and Bimali, Milan and Brown, Ginger and Crane, Jasmine and Darwish, Nadia and Faulkner, Jennifer L and Govindarajan, Rangaswamy and Johnson, Aaron and Kurilung, Alongkorn and Lazarenko, Oxana and Lu, Yong-Chen William and Marsh, Keanna and Moreno, Mauricio and Nookaew, Intawat and Robeson, Michael and Sunde, Jumin and Ussery, David and Vural, Emre and Wilman, Mindy and Nakagawa, Mayumi},
  title = {A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence},
  journal = {Oncotarget},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {291--305},
  doi = {10.18632/oncotarget.28892}
}
Kostenlos starten →